Shen Mi, member of the Standing Committee of CPC Suzhou Committee and secretary of CPC SIP Working Committee, met with the delegation of Integra LifeSciences, a global leader in medical technology with headquarters in Princeton, New Jersey, the United States, in SIP on Mar 5. The two parties discussed plans for future cooperation.
Founded in 1989, Integra LifeSciences started out with medical technology for burns surgery, and now it is a global leader in neurosurgery. The company signed an agreement with SIP Administrative Committee last September to set up its first manufacturing and testing facility in China.
During the meeting, Shen extended warm welcome to the guests, gave them an introduction to SIP’s business environment for medical devices companies, and congratulated Integra LifeSciences on the opening of its branch in SIP.
Lea Daniels Knight, executive vice president and CFO of Integra LifeSciences, expressed thanks to SIP authorities for the support to the company’s project in SIP. She said Integra LifeSciences would like to invest more in SIP to bring more quality products to patients in China.
On the afternoon of the same day, the Integra LifeSciences branch was opened in SIP. It is expected to launch manufacturing of two products for restoration and repair of dura mater and intracranial pressure monitoring between 2025 and 2027, and then add another eight products within a period of five years.
March 6, 2024
